MedTrace Logo

Laparoscopic Hernia Defect Obliteration With ProFlor-E

NCT04718298 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2021-09-29

No results posted yet for this study

Summary

This feasibility study highlights the features of the 3D dynamic responsive prosthesis ProFlor-E® for fixation free obliteration of inguinal hernia defect

Conditions

  • Inguinal Hernia

Interventions

DEVICE

ProFlor laparoscopic technique

Inguinal hernia repair laparoscopic

Sponsors & Collaborators

  • University of Cagliari

    lead OTHER

Principal Investigators

  • Giuseppe Amato, MD · University of Cagliari - University of Palermo

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-01
Primary Completion
2021-06-01
Completion
2021-06-01
FDA Device
Yes

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04718298 on ClinicalTrials.gov